Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis

Alexander Nikoloudis; Veronika Buxhofer-Ausch; Irene Strassl; Olga Stiefel; Sigrid Machherndl-Spandl; Andreas Petzer; Johannes Clausen; et al.

doi:10.1111/ejh.13956

Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis

Alexander Nikoloudis
, Veronika Buxhofer-Ausch
, Irene Strassl
, Olga Stiefel
, Sigrid Machherndl-Spandl
, Andreas Petzer
, Johannes Clausen
, et al.

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	715-724
Number of pages	10
Journal	European Journal of Haematology
Volume	110
Issue number	6
DOIs	https://doi.org/10.1111/ejh.13956
Publication status	Published - Jun 2023

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

Access to Document

10.1111/ejh.13956

Cite this

Nikoloudis, A., Buxhofer-Ausch, V., Strassl, I., Stiefel, O., Machherndl-Spandl, S., Petzer, A., Clausen, J., & et al. (2023). Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis. European Journal of Haematology, 110(6), 715-724. https://doi.org/10.1111/ejh.13956

@article{8c8ff7c4324f40b59d546d185af9b910,

title = "Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis",

author = "Alexander Nikoloudis and Veronika Buxhofer-Ausch and Irene Strassl and Olga Stiefel and Sigrid Machherndl-Spandl and Andreas Petzer and Johannes Clausen and \{et al.\}",

year = "2023",

month = jun,

doi = "10.1111/ejh.13956",

language = "English",

volume = "110",

pages = "715--724",

journal = "European Journal of Haematology",

issn = "1600-0609",

number = "6",

}

Nikoloudis, A, Buxhofer-Ausch, V, Strassl, I, Stiefel, O, Machherndl-Spandl, S, Petzer, A, Clausen, J & et al. 2023, 'Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis', European Journal of Haematology, vol. 110, no. 6, pp. 715-724. https://doi.org/10.1111/ejh.13956

Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis. / Nikoloudis, Alexander; Buxhofer-Ausch, Veronika; Strassl, Irene et al.
In: European Journal of Haematology, Vol. 110, No. 6, 06.2023, p. 715-724.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis

AU - Nikoloudis, Alexander

AU - Buxhofer-Ausch, Veronika

AU - Strassl, Irene

AU - Stiefel, Olga

AU - Machherndl-Spandl, Sigrid

AU - Petzer, Andreas

AU - Clausen, Johannes

AU - et al., null

PY - 2023/6

Y1 - 2023/6

UR - https://pubmed.ncbi.nlm.nih.gov/36941654/

UR - https://www.scopus.com/pages/publications/85152003308

U2 - 10.1111/ejh.13956

DO - 10.1111/ejh.13956

M3 - Article

SN - 1600-0609

VL - 110

SP - 715

EP - 724

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 6

ER -

Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis

Fields of science

Access to Document

Other files and links

Cite this